We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 4.50 | 4.86% | 97.00 | 90.00 | 100.00 | 95.00 | 92.50 | 92.50 | 18,552 | 16:35:24 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investment Advice | 24k | -17.01M | -0.2722 | -3.49 | 59.35M |
Hot Features
Premium
RNS Number:3910S
Celsis International PLC
24 November 2003
CELSIS INTERNATIONAL PLC
Disposal of Shares
Celsis International plc ("Celsis" or "the Company") advises that on 21 November
a Director of the Company, Professor Sir Christopher Evans OBE, sold 5,300,000
ordinary shares at 31p per share by way of a Placing by the Company's broker,
Seymour Pierce Limited, to meet ongoing institutional demand for Celsis' shares.
Sir Christopher was a founding shareholder of Celsis and is a renowned venture
capitalist in the UK Life Sciences industry most recently through his fund
Merlin Ventures, and this is the first time he has sold shares. Sir Christopher
will retain a significant stake in the Company of 6,595,250 shares, which is
approximately 5.9% of the issued share capital. Sir Christopher has confirmed
his ongoing confidence in Celsis and its management and remains a Non-Executive
on the Board.
24 November 2003
Enquiries:
Seymour Pierce Limited Tel: 020 7107 8000
Jonathan Wright
College Hill Tel: 020 7457 2020
Nicholas Nelson/ Corinna Dorward
For more information on Celsis International plc go to www.celsis.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
DISPUGMGGUPWGRG
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
